Patents by Inventor Arthur D. Newell

Arthur D. Newell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human IL-2 as a vaccine adjuvant
    Patent number: 6060068
    Abstract: Methods for enhancing the immune response to vaccination in animals, including humans, comprise administering interleukin-2 (IL-2) as part of the vaccination regimen, preferably for 5 to 14 days post-vaccination. In addition, compositions for enhancing the immune response of an animal to a vaccine employ IL-2 as an active ingredient, preferably human IL-2.
    Type: Grant
    Filed: August 31, 1998
    Date of Patent: May 9, 2000
    Assignee: Chiron Corporation
    Inventors: Michael V. Doyle, Arthur D. Newell, Jack H. Nunberg, Thomas J. White
  • Human IL-2 as a vaccine adjuvant
    Patent number: 5800810
    Abstract: Methods for enhancing the immune response to vaccination in animals, including humans, comprise administering interleukin-2 (IL-2) as part of the vaccination regimen, preferably for 5 to 14 days post-vaccination. In addition, compositions for enhancing the immune response of an animal to a vaccine employ IL-2 as an active ingredient, preferably human IL-2.
    Type: Grant
    Filed: October 17, 1996
    Date of Patent: September 1, 1998
    Assignee: Chiron Corporation
    Inventors: Michael V. Doyle, Arthur D. Newell, Jack H. Nunberg, Thomas J. White
  • Human IL-2 as a vaccine adjuvant
    Patent number: 5643565
    Abstract: Methods for enhancing the immune response to vaccination in animals, including humans, comprise administering interleukin-2 (IL-2) as part of the vaccination regimen, preferably for 5 to 14 days post-vaccination. In addition, compositions for enhancing the immune response of an animal to a vaccine employ IL-2 as an active ingredient, preferably human IL-2.
    Type: Grant
    Filed: May 24, 1995
    Date of Patent: July 1, 1997
    Assignee: Chiron Corporation
    Inventors: Michael V. Doyle, Arthur D. Newell, Jack H. Nunberg, Thomas J. White
  • Human IL-2 as a vaccine adjuvant
    Patent number: 5503841
    Abstract: Methods for enhancing the immune response to vaccination in animals, including humans, comprise administering interleukin-2 (IL-2) as part of the vaccination regimen, preferably for 5 to 14 days post-vaccination. In addition, compositions for enhancing the immune response of an animal to a vaccine employ IL-2 as an active ingredient, preferably human IL-2.
    Type: Grant
    Filed: February 24, 1989
    Date of Patent: April 2, 1996
    Assignee: Cetus Oncology Corporation
    Inventors: Michael V. Doyle, Arthur D. Newell, Jack H. Nunberg, Thomas J. White
  • Human IL-2 as a vaccine adjuvant
    Patent number: 5100664
    Abstract: Methods for enhancing the immune response to vaccination in animals, including humans, comprise administering interleukin-2 (IL-2) as part of the vaccination regimen, preferably for 5 to 14 days post-vaccination. In addition, compositions for enhancing the immune response of an animal to a vaccine employ IL-2 as an active ingredient, preferably human IL-2.
    Type: Grant
    Filed: June 30, 1989
    Date of Patent: March 31, 1992
    Assignee: Cetus Corporation
    Inventors: Michael V. Doyle, Arthur D. Newell, Jack H. Nunberg, Thomas J. White, Gary A. Anderson